Blue Shield Pharma

The Nanjing Qixia District People’s Court has accepted a bankruptcy liquidation case for Blue Shield Pharma, a China-based pharmaceutical company specializing in tumor drug development. The move comes after Blue Shield Pharma failed to meet its debt obligations. As of April 9, 2024, the company’s total employee debt stood at…